• Nachrichtendetail
• 

01.04.2024 02:34:39 - dpa-AFX: *EISAI COMPLETES SUBMISSION OF LEQEMBI SBLA FOR IV MAINTENANCE DOSING FOR TREATMENT OF EARLY ALZHEIMER'S DISEASE TO FDA

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	BIOGEN INC. DL -,0005	789617	Frankfurt	208,300	21.06.24 20:38:57	+1,700	+0,82%	0,000	0,000	209,500	206,600